The Claim
Rapamycin extends lifespan in genetically heterogeneous mice, with statistically significant lifespan extension benefits observed in both male and female mice at each of three independent research institutions (The Jackson Laboratory, University of Michigan, and University of Texas Health Science Center).
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
A drug called rapamycin helps mice live longer, and scientists have confirmed this works in three different labs - the results show both male and female mice benefit.
See the scientific wording
The lifespan extension effect of rapamycin is consistent across three independent test sites (The Jackson Laboratory, University of Michigan, and University of Texas Health Science Center) in genetically heterogeneous mice, with statistically significant benefits observed in both males and females at each site.
What the research says
1 studyStudy: Rapamycin fed late in life extends lifespan in genetically heterogeneous mice
This study fed rapamycin to mice and found that it extended their lifespan. The researchers tested this at three different labs with genetically diverse mice and found the lifespan extension worked for both male and female mice at all three locations, exactly matching what the claim says.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.